Recent Stories
- Kevin Hill, MD (Addiction Psychiatry, BIDMC) and Mia Hazel, MD (Addiction Psychiatry BIDMC), shared data showing those with addictions are eight times more likely than those without to get COVID-19. They have found that increasing the frequency of virtual appointments has been essential for helping patients stay engaged in recovery treatment.
- Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to recently emerged data from the Johnson & Johnson trial where researchers looked for signs of infection in 3,000 participants up to 71 days after getting the single-dose vaccine. Risk of infection in that study seemed to fall by about 74 percent.
- Pharmaceutical giant Merck will help manufacture the newly authorized Johnson & Johnson single-shot COVID-19 vaccine. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) shared that the collaboration could greatly accelerate the rollout of the Johnson & Johnson vaccine at a time when acceleration of the vaccine campaign in the US and throughout the world is needed.
- The first round of voting for STAT Madness began today. Included in the first round is the BIDMC team, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), who in collaboration with Johnson & Johnson developed and conducted preclinical testing of a single-dose COVID-19 vaccine, which is one of three COVID-19 vaccines cleared for emergency use in the U.S.
- FDA issues emergency use authorization for Johnson & Johnson vaccine
